ProfileGDS4718 / 210356_x_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 38% 42% 33% 31% 43% 42% 42% 41% 58% 35% 41% 83% 38% 40% 42% 65% 47% 39% 40% 30% 31% 44% 32% 34% 63% 40% 30% 38% 36% 40% 52% 36% 46% 44% 34% 38% 42% 58% 65% 30% 53% 43% 35% 47% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]4.9244238
GSM549102patient 115, normal, homogenized [OPG study]5.0988942
GSM549104patient 119, normal, homogenized [OPG study]4.6506433
GSM549108patient 138, normal, homogenized [OPG study]4.6113231
GSM549119patient 077, normal, homogenized [OPG study]5.1289743
GSM549133patient 032, cancer, homogenized [OPG study]5.0128942
GSM549139patient 042, cancer, homogenized [OPG study]5.0542
GSM549099patient 107, normal, homogenized [OPG study]5.0404541
GSM549109patient 139, normal, homogenized [OPG study]5.9940958
GSM549110patient 046, normal, homogenized [OPG study]4.7444735
GSM549114patient 063, normal, homogenized [OPG study]4.9813841
GSM549122patient 082, normal, homogenized [OPG study]8.2514183
GSM549134patient 033, cancer, homogenized [OPG study]4.8957338
GSM549136patient 036, cancer, homogenized [OPG study]4.9259940
GSM549140patient 044, cancer, homogenized [OPG study]5.0529542
GSM549111patient 047, normal, homogenized [OPG study]6.5224665
GSM549113patient 057, normal, homogenized [OPG study]5.2806147
GSM549132patient 031, cancer, homogenized [OPG study]4.9375839
GSM549137patient 038, cancer, homogenized [OPG study]4.966540
GSM549142patient 047, cancer, homogenized [OPG study]4.6560430
GSM549100patient 110, normal, homogenized [OPG study]4.5857131
GSM549107patient 135, normal, homogenized [OPG study]5.1841144
GSM549115patient 068, normal, homogenized [OPG study]4.5687232
GSM549116patient 072, normal, homogenized [OPG study]4.6912934
GSM549120patient 078, normal, homogenized [OPG study]6.3023463
GSM549131patient 030, cancer, homogenized [OPG study]4.9250840
GSM549118patient 074, normal, homogenized [OPG study]4.5448830
GSM549129patient 027, cancer, homogenized [OPG study]4.8982338
GSM549123patient 088, normal, homogenized [OPG study]4.7663236
GSM549124patient 006, cancer, homogenized [OPG study]5.0461640
GSM549126patient 015, cancer, homogenized [OPG study]5.6382552
GSM549128patient 025, cancer, homogenized [OPG study]4.769936
GSM549103patient 117, normal, homogenized [OPG study]5.3634346
GSM549117patient 073, normal, homogenized [OPG study]5.1724344
GSM549138patient 041, cancer, homogenized [OPG study]4.7002234
GSM549141patient 045, cancer, homogenized [OPG study]4.8402238
GSM549130patient 028, cancer, homogenized [OPG study]5.1122142
GSM549101patient 111, normal, homogenized [OPG study]6.0482258
GSM549105patient 128, normal, homogenized [OPG study]6.5088465
GSM549106patient 134, normal, homogenized [OPG study]4.5091430
GSM549112patient 048, normal, homogenized [OPG study]5.662953
GSM549125patient 011, cancer, homogenized [OPG study]5.156843
GSM549127patient 024, cancer, homogenized [OPG study]4.7607735
GSM549135patient 035, cancer, homogenized [OPG study]5.2963247